See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 12, 2006

Heartburn Solid Tumors Diabetes - Type 1

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:


This study is evaluating an investigational medication to treat frequent heartburn. To pre-qualify, you must be 18 or older and must have had heartburn at least two days per week over the past month. Participants will receive a study-related medical evaluation and the investigational medication at no cost. Reimbursement for travel will be provided.

The research site is in Richmond, Va.

More information

Please see


Solid Tumors

This study will investigate a new anti-cancer drug called AMT. Volunteers who have cancer confirmed by histology or cytology, at least one measurable lesion, advanced disease refractory to standard therapy or for which no standard therapy exists, and life expectancy of at least three months may qualify.

The research site is in Baden Wuerttemberg, Germany.

More information

Please see


Diabetes - Type 1

People between ages 18 and 60 with type 1 diabetes mellitus are needed for a research study of an investigational monoclonal antibody. Candidates must be generally in good health with a history of type 1 diabetes mellitus, must be willing to stay in the clinic overnight, and must have been on a stable dose of any existing medications for four weeks. Multiple blood draws will be required.

The research site is in Lenexa, Kan.

More information

Please see


Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.